Skip to content

Clinical trials

Phase 3 Acromegaly trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acromegaly Phase: Phase 3 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20083
20101
20111
20121
20161
20171
20192
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chiasma, Inc.3
Camurus AB2
Crinetics Pharmaceuticals Inc.2
Endo USA Inc., a Keenova Therapeutics Company2
Novartis Pharmaceuticals2
Ambrilia Biopharma, Inc.1
Debiopharm International SA1
Ipsen1
National Institute of Dental and Craniofacial Research (NIDCR)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acromegaly15
Adenoma1
Fibrous Dysplasia, Polyostotic1
Gigantism1
Hyperplasia1
Pituitary Diseases1
Pituitary Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.